- Home
- SCWO vs FENC Comparison
SCWO vs FENC Comparison
Compare SCWO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCWO | FENC |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.8M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | SCWO | FENC |
|---|---|---|
| Price | $0.25 | $7.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.1M | 166.4K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,910,340.00 | ★ $38,790,000.00 |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | $75.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 508.52 | N/A |
| 52 Week Low | $0.16 | $4.68 |
| 52 Week High | $1.09 | $9.92 |
Technical Indicators
Market Signals| Indicator | SCWO | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 44.23 |
| Support Level | $0.19 | $7.35 |
| Resistance Level | $0.30 | $8.00 |
| Average True Range (ATR) | 0.03 | 0.33 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 43.25 | 23.33 |
Price Performance
Historical ComparisonAbout SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.